Comparison of Patients Classified as High-Risk between International Cardiovascular Disease Primary Prevention Guidelines.

ABSTRACT: Background: Cardiovascular disease (CVD) primary prevention guidelines classify people at high risk and recommended for pharmacological treatment based on clinical criteria and absolute CVD risk estimation. Despite relying on similar evidence, recommendations vary between international guidelines, which may impact who is recommended to receive treatment for CVD prevention. Objective: To determine the agreement in treatment recommendations according to guidelines from Australia, England and the United States. Methods: Cross-sectional analysis of the National Health and Nutrition Examination Survey (n = 2647). Adults ≥ 40 years were classified as high-risk and recommended for treatment according to Australia, England and United States CVD prevention guidelines. Agreement

SUBMITTER: Chapman N 

PROVIDER: S-EPMC11312975 | biostudies-literature | 2024 Jul

REPOSITORIES: biostudies-literature